Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Rohto Pharmaceutical to Offer Three Regenerative Drugs by 2020

Filed Under: Innovation, Pharma, Products Tagged With: , ,

Rohto Pharmaceutical Co. Ltd. (TYO:4527) plans to put three new regenerative medical drugs on the market by 2020, using a…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Teijin Expands Health Care Operations for Bone and Joint Diseases
Teijin Expands Health Care Operations for Bone and Joint…
Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Keio University Venture Looks to Achieve Breakthrough in…
Coronavirus Report – Part 24: Survey Reveals 12 Japanese Pharmaceutical Firms Working to Develop Cures
Coronavirus Report – Part 24: Survey Reveals 12 Japanese…